SCHEMBL17211814

SCHEMBL17211814

C=CCC1(COC)CCc2cc(C(=C)/C=C\C(=C)[N+](=O)[O-])ccc2C1=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14137101 0.76 DGAT1 (0.38) —
SCHEMBL17211807 0.76 ALDH1A1 (0.33) —
SCHEMBL17211817 0.76 DGAT1 (0.35) —
SCHEMBL17211816 0.71 CYP26A1 (0.31) —
SCHEMBL17211810 0.70 MAOA (0.44) —
SCHEMBL629836 0.68 SMN1; SMN2 (0.53) —
SCHEMBL17211805 0.68 SIRT2 (0.30) —
SCHEMBL17211822 0.68 KDM1A (0.33) —
SCHEMBL17211812 0.68 — —
SCHEMBL17211813 0.67 CYP26A1 (0.32) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9242929-B2 Compounds as diacylglycerol acyltransferase inhibitors GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO.2) LIMITED (GB) 2016-01-26 — — US disclosed
US-20150307445-A1 Novel Compounds as Diacylglycerol Acyltransferase Inhibitors GlaxoSmith Kline Intellectual Property (No.2) Limited (GB) 2015-10-29 — — US disclosed
Send feedback